National Pharmaceutical Pricing Authority

(Published in Part II, Section 3, Sub-section (ii) of

the Gazette of India, Extraordinary, dated the 27^th November, 2008)

Government of India

Ministry of Chemicals and Fertilizers

National Pharmaceutical Pricing Authority

New Delhi, the 27^th November, 2008

ORDER

S.O. 2807(E)- In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637 (E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers, (National Pharmaceutical Pricing Authority) No. S.O. 776(E), dated 28^th March, 2008, the National Pharmaceutical Pricing Authority, hereby fixes/revises the prices as specified in column (5) of the table hereto annexed as the retail price/revised retail price, exclusive of excise duty, Sales Taxes/VAT and local taxes, if any, and in column (6) as equivalent MRP inclusive of excise duty, education cess, Sales Tax/VAT in relation to each of the formulation specified in the corresponding entry in column (2) of the said table with the pack size specified in the corresponding entries in column (3) thereof; manufactured/imported by M/s. WockhardtLtd..

TABLE

Sl. No.	Name of the formulation	Pack Size	Existing Retail Price Excise (Rs.)	Retail Price without Excise Duty Sales Tax /VAT and Local Tax, if any (Rs.)	Equivalent MRP* inclusive of all taxes (Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
1	Wosulin R 40 IU Each ml Isophane suspension contain Human Insulin – 40 IUM- Cresol 0.25% w/v (as preservative)	10ml Vial	112.96	120.08	124.88
2	Wosulin N 40IU Each ml Isophane suspension contain Human Insulin – 40 IU M- Cresol 0.25% w/v (as preservative) Phenol 0.065% w/v (as preservative)	10ml Vial	113.18	120.10	--
3	Wosulin 50/50 Each ml contain Human Insulin – 40 IU(50% solube insulin injection &50% Isophane Insulin Injection)M- Cresol 0.16% w/v (as preservative)Phenol 0.065% w/v (as preservative)	10ml Vial	113.06	120.10	124.90
4	Wosulin 30/70 Each ml contain Human Insulin – 40 IU (30% solube insulin injection & 70% Isophane Insulin Injection) M- Cresol 0.16% w/v (as preservative) Phenol 0.065% w/v (as preservative)	10ml Vial	113.12	120.10	124.90
5	Wosulin N 100IU/ml Each ml of isophane suspension contain Insulin Human USP 100IU M-cresol USP 0.16% w/v preservative Phenol IP 0.065% w/v preservative Water for Injection q. s	3ml Cartridge	89.95	110.88	115.32
6	Wosulin R 100IU/ml Each ml contain Insulin Human USP 100IU Insulin Human USP 100IU Insulin Human USP 100IUWater for Injection q. s	3ml Cartridge	89.75	110.88	115.32
7	Wosulin 50/50 100IU/ml Each ml contain Insulin Human USP 100IU(50% Insulin Human neutral and50% Isophane Insulin) M-cresol USP 0..16% w/v preservative Phenol IP 0.065% w/v preservative Water for Injection q. s	3ml Cartridge	89.85	110.88	115.32
8	Wosulin 30/70 100IU/ml Each ml contain Insulin Human USP 100IU(30% Insulin Human neutral and70% Isophane Insulin) M-cresol USP 0..16% w/v preservative Phenol IP 0.065% w/v preservativeWater for Injection q. s	3ml Cartridge	92.21	110.88	115.32
9	Wosulin N Dispo Pen Each ml of Isophane suspension contain Insulin Human USP 100IUM-cresol USP 0.16% w/v preservative Phenol IP 0.065% w/v preservative Water for Injection q. s	3ml Cartridge	202.88	188.23	195.76
10	Wosulin R Dispo Pen Each ml contain Insulin Human USP 100IU M-cresol USP 0.25% w/v preservative Water for Injection q. s	3ml Cartridge	202.88	188.23	195.76
11	Wosulin R Dispo Pen Each ml contain Insulin Human USP 100IU M-cresol USP 0.25% w/v preservative Water for Injection q. s	3ml Cartridge with Disposable Pen	202.88	188.23	195.76
12	Wosulin 30/70 Dispo PenEach ml contain Insulin Human USP 100IU (30% Insulin Human neutral and 70% Isophane Insulin)M-cresol USP 0..16% w/v preservative Phenol IP 0.065% w/v preservativeWater for Injection q. s	3ml Cartridge with Disposable Pen	202.88	188.23	195.76

*Subject to actual payment of Government levies/taxes, as applicable.

Note :

(a) The prices fixed are the maximum retail prices in column no. (6) (inclusive of excise duty, sales tax/VAT and local taxes if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.

(b) The companies / manufacturers may added taxes only if they have paid actually to the Government on the price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.

(c) For different packing material used or any special feature claimed, companies are required to approach NPPA for approval/fixation of specific prices.

(d) The manufacturer and marketing company for the above said formulation shall be required to take the requisite prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.

(e) These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.

(f) These prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.

PN/105/2008/F

F. No. 8(14)/2008/D.P./NPPA-Div.-II

(RAJIV WADHAWAN)

Deputy Director

Last Page Updated: 01-06-2019

Note :Website Content Managed by National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Designed, Developed and Hosted by National Informatics Centre Services Inc.(NICSI)